Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria
- ViiV Healthcare shares data from landmark 2-drug regimen trials at AIDS 2018
- US FDA Advisory Committee endorses the effectiveness and safety of single-dose tafenoquine for the radical cure of P. vivax malaria
Tweets from GSK
-
GSK @GSK
Our new medicine to combat relapsing #malaria tackles a disease that causes 8.5 million infections a year.
about 7 hours ago -
GSK @GSK
#NEWS: Thanks to #FDA approval, @GSK and @MMV will offer the first new medicine in over 60 years for relapsing #malaria. gsk.to/2LpFaKh
about 1 day ago
-
GSK @GSK
#HIV is a key area of research for us, through our dedicated global leading HIV company, @ViiVHC. See how our scientists are working to find a cure: gsk.to/2H84HSb #BehindTheScience
about 1 day ago
